Literature DB >> 25979412

Refractory and resistant hypertension: characteristics and differences observed in a specialized clinic.

Rodrigo Modolo1, Ana Paula de Faria2, Andréa Rodrigues Sabbatini2, Natália Ruggeri Barbaro2, Alessandra M V Ritter2, Heitor Moreno2.   

Abstract

Resistant hypertension (RH) is defined as uncontrolled blood pressure (BP) despite the use of ≥3 anti-hypertensive drugs, or controlled requiring use of ≥4 drugs. Recently, a new definition for an extreme phenotype of RH (uncontrolled BP using at least five drugs) has emerged-the refractory hypertension (RfH). Although characteristics of RH are well established, little is known about this newly described subgroup. For this work, 116 subjects with RH were enrolled from a specialized clinic and divided into RH (n = 80) and RfH (n = 36). Subjects were submitted to echocardiography, 24-hour ambulatory BP measurement and biochemical analyses. Logistic regression analysis demonstrated that: (1) white-coat effect (odds ratio [OR], 3.23; 95% confidence interval [CI], 1.12-9.27; P = .03), (2) black race (OR, 6.67; 95% CI, 1.99-16.16; P < .001), and (3) left ventricular mass index (OR, 1.02; 95% CI, 1.01-1.03; P = .04) were independent predictors of refractoriness. In conclusion, RfH and RH present different patient characteristics, and these phenotypic aspects can be useful for better understanding this harder-to-treat subgroup.
Copyright © 2015 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Left ventricular hypertrophy; high blood pressure; white-coat effect

Mesh:

Substances:

Year:  2015        PMID: 25979412     DOI: 10.1016/j.jash.2015.03.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  18 in total

Review 1.  Resistant Hypertension: An Update of Experimental and Clinical Findings.

Authors:  Anping Cai; David A Calhoun
Journal:  Hypertension       Date:  2017-05-15       Impact factor: 10.190

Review 2.  The Potential Role of Obstructive Sleep Apnoea in Refractory Hypertension.

Authors:  Grace Oscullo; E Sapiña-Beltrán; Gerard Torres; Enrique Zaldivar; Ferran Barbé; Miguel Angel Martinez-Garcia
Journal:  Curr Hypertens Rep       Date:  2019-06-10       Impact factor: 5.369

3.  Hypertension-Linked Pathophysiological Alterations in the Gut.

Authors:  Monica M Santisteban; Yanfei Qi; Jasenka Zubcevic; Seungbum Kim; Tao Yang; Vinayak Shenoy; Colleen T Cole-Jeffrey; Gilberto O Lobaton; Daniel C Stewart; Andres Rubiano; Chelsey S Simmons; Fernando Garcia-Pereira; Richard D Johnson; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2016-10-31       Impact factor: 17.367

Review 4.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 5.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

Review 6.  Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.

Authors:  Tanja Dudenbostel; Mohammed Siddiqui; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190

Review 7.  Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?

Authors:  J C Yugar-Toledo; V Brunelli; J F Vilela-Martin; A Fattori; H Moreno
Journal:  Curr Hypertens Rep       Date:  2018-03-27       Impact factor: 5.369

8.  Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes.

Authors:  Alejandro Velasco; Mohammed Siddiqui; Eric Kreps; Pavani Kolakalapudi; Tanja Dudenbostel; Garima Arora; Eric K Judd; Sumanth D Prabhu; Steven G Lloyd; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2018-06-04       Impact factor: 10.190

Review 9.  Treatment of Resistant and Refractory Hypertension.

Authors:  Maria Czarina Acelajado; Zachary H Hughes; Suzanne Oparil; David A Calhoun
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

10.  Refractory versus resistant hypertension: Novel distinctive phenotypes.

Authors:  Tanja Dudenbostel; Mohammed Siddiqui; Nitin Gharpure; David A Calhoun
Journal:  J Nat Sci       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.